bunazosin has been researched along with Prostatic Diseases in 1 studies
bunazosin: structure
Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A dosage of 12 mg/day did not improve subjective symptoms more than did the 9 mg/day dose." | 2.66 | [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction]. ( Kondo, A; Mitsuya, H; Otani, T; Takita, T, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takita, T | 1 |
| Kondo, A | 1 |
| Mitsuya, H | 1 |
| Otani, T | 1 |
1 trial available for bunazosin and Prostatic Diseases
| Article | Year |
|---|---|
[Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; | 1987 |